Therapeutic class

Antinéoplasique, anticorps monoclonal (anti-CD38)

3 drugs listed in Morocco

This page lists drugs marketed in Morocco belonging to the therapeutic class "Antinéoplasique, anticorps monoclonal (anti-CD38)". For each entry, you'll find the brand name, composition (DCI), dosage, galenic form, manufacturer, public selling price (PPV in MAD) and reimbursement status (CNSS / CNOPS). Primary source: Direction du Médicament et de la Pharmacie (DMM), Ministry of Health.

DARZALEX 1800 MG

1800 MG · Solution injectable (SC) en flacon

Generic

Daratumumab

Antinéoplasique, anticorps monoclonal (anti-CD38)

MAPHAR

51,837 MAD

DARZALEX 20 MG / ML

20 MG · Solution à diluer pour perfusion

Generic

Daratumumab

Antinéoplasique, anticorps monoclonal (anti-CD38)

MAPHAR

19,423 MAD

DARZALEX 20 MG / ML

20 MG · Solution à diluer pour perfusion

Generic

Daratumumab

Antinéoplasique, anticorps monoclonal (anti-CD38)

MAPHAR

5,155 MAD

← All therapeutic classes